IN2014CN04050A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04050A
IN2014CN04050A IN4050CHN2014A IN2014CN04050A IN 2014CN04050 A IN2014CN04050 A IN 2014CN04050A IN 4050CHN2014 A IN4050CHN2014 A IN 4050CHN2014A IN 2014CN04050 A IN2014CN04050 A IN 2014CN04050A
Authority
IN
India
Prior art keywords
arylglucosides
useful
building block
present
provides processes
Prior art date
Application number
Other languages
English (en)
Inventor
Julian Paul Henschke
Chen Wei Lin
ping yu Wu
Chi Nung Hsiao
Jyh Hsiung Liao
Tsung Yu Hsiao
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of IN2014CN04050A publication Critical patent/IN2014CN04050A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN4050CHN2014 2011-11-07 2012-11-07 IN2014CN04050A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161556780P 2011-11-07 2011-11-07
US201261661793P 2012-06-19 2012-06-19
PCT/IB2012/002894 WO2013068850A2 (en) 2011-11-07 2012-11-07 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES

Publications (1)

Publication Number Publication Date
IN2014CN04050A true IN2014CN04050A (ru) 2015-07-10

Family

ID=48290709

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4050CHN2014 IN2014CN04050A (ru) 2011-11-07 2012-11-07

Country Status (11)

Country Link
EP (1) EP2776449B1 (ru)
JP (1) JP6144686B2 (ru)
KR (1) KR101756772B1 (ru)
CN (1) CN103974964B (ru)
AU (1) AU2012335280B2 (ru)
BR (1) BR112014010997A2 (ru)
CA (1) CA2854591A1 (ru)
IL (1) IL232418A (ru)
IN (1) IN2014CN04050A (ru)
TW (1) TWI488861B (ru)
WO (1) WO2013068850A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557894A (zh) * 2013-10-18 2015-04-29 上海信谊药厂有限公司 坎格列汀晶型及其制备方法
TWI592418B (zh) * 2014-04-11 2017-07-21 台灣神隆股份有限公司 β-C-芳基葡萄糖苷之製造方法
CN105017237A (zh) * 2014-04-29 2015-11-04 嘉实(湖南)医药科技有限公司 一种卡格列净的制备工艺
EP2947077A1 (en) 2014-05-19 2015-11-25 LEK Pharmaceuticals d.d. Stereoselective synthesis of intermediates in the preparation of ß-C-arylglucosides
US10370365B2 (en) 2015-09-16 2019-08-06 Optimus Drugs (P) Limited Process for the preparation of Canagliflozin
CN105294624B (zh) * 2015-11-16 2018-01-12 山东罗欣药业集团股份有限公司 一种达格列净的制备方法
CN105486767B (zh) * 2015-12-03 2018-03-13 上海应用技术学院 一种达格列净及其α‑异构体的分离方法
CN105541815B (zh) * 2015-12-24 2018-07-13 寿光富康制药有限公司 一种卡格列净的制备方法
EP4114365A1 (en) 2020-03-05 2023-01-11 KRKA, d.d., Novo mesto Pharmaceutical composition comprising sglt2 inhibitor
CN115867538A (zh) 2020-06-05 2023-03-28 新梅斯托克公司 高纯的无定形达格列净的制备

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872599A (ja) * 1981-10-27 1983-04-30 Kanto Ishi Pharma Co Ltd 複合糖質誘導体
US7375213B2 (en) * 2003-01-03 2008-05-20 Bristol-Myers Squibb Company Methods of producing C-aryl glucoside SGLT2 inhibitors
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
CN102762583A (zh) 2009-11-24 2012-10-31 南非医学研究院 合成阿司巴汀及其类似物的方法

Also Published As

Publication number Publication date
EP2776449A2 (en) 2014-09-17
EP2776449B1 (en) 2017-08-02
WO2013068850A3 (en) 2013-08-22
IL232418A (en) 2016-10-31
TWI488861B (zh) 2015-06-21
EP2776449A4 (en) 2015-10-07
CA2854591A1 (en) 2013-05-16
WO2013068850A2 (en) 2013-05-16
KR101756772B1 (ko) 2017-07-26
JP6144686B2 (ja) 2017-06-07
TW201335175A (zh) 2013-09-01
JP2014532690A (ja) 2014-12-08
CN103974964A (zh) 2014-08-06
WO2013068850A8 (en) 2013-10-10
AU2012335280B2 (en) 2016-09-29
AU2012335280A1 (en) 2014-05-22
KR20140089427A (ko) 2014-07-14
CN103974964B (zh) 2016-03-23
IL232418A0 (en) 2014-06-30
BR112014010997A2 (pt) 2017-06-06

Similar Documents

Publication Publication Date Title
PH12016500739A1 (en) Inhibitors of the fibrolast growth factor receptor
IN2014CN04050A (ru)
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
MX355728B (es) Inhibidores de cinasas.
IN2015DN00127A (ru)
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
IN2012DN06714A (ru)
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
UA111186C2 (ru) Способы и композиции для получения норибогаина из воакангина
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
MX337094B (es) Proceso e intermediarios para preparar inhibidores de integrasa.
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
IN2014DN09450A (ru)
IN2013MU00848A (ru)
IN2014DN06738A (ru)
EP3302486A4 (en) Dihydropyrazolopyrimidinone compounds as pde2 inhibitors
IN2014CN00312A (ru)
HRP20190286T1 (hr) Postupci za pripremu spojeva, kao što su 3-arilbutanali, korisni u sintezi medetomidina
EP2885302A4 (en) PROCESS FOR THE PREPARATION OF DIPEPTIDYLPEPTIDASE INHIBITORS
WO2012106702A3 (en) Treatment of leukemia
IN2014DN10209A (ru)
IN2015DN02513A (ru)
EP3291817A4 (en) Heteroaryl-pyrimidinone compounds as pde2 inhibitors
IN2013CH05395A (ru)
IN2015KN00386A (ru)